188 related articles for article (PubMed ID: 32218854)
1. Development of a nine-lncRNA signature as a novel prognostic marker of estrogen receptor-negative breast cancer.
Wang Z; Wang J; Liu L; He Q; Wei M
Oncol Lett; 2020 Apr; 19(4):2979-2988. PubMed ID: 32218854
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
3. Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hong J; Chen H; Fang JY
J Cancer; 2017; 8(13):2575-2586. PubMed ID: 28900495
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
6. Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer.
Li J; Wang W; Xia P; Wan L; Zhang L; Yu L; Wang L; Chen X; Xiao Y; Xu C
Int J Cancer; 2018 Nov; 143(9):2150-2160. PubMed ID: 29707762
[TBL] [Abstract][Full Text] [Related]
7. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
[TBL] [Abstract][Full Text] [Related]
8. A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.
Zhong L; Lou G; Zhou X; Qin Y; Liu L; Jiang W
Oncotarget; 2017 Sep; 8(40):67861-67870. PubMed ID: 28978079
[TBL] [Abstract][Full Text] [Related]
9. Nine-long non-coding ribonucleic acid signature can improve the survival prediction of colorectal cancer.
Zong Z; Hu CG; Zhou TC; Yu ZM; Tang FX; Tian HK; Li H; Wang H
World J Gastrointest Surg; 2021 Feb; 13(2):210-221. PubMed ID: 33643540
[TBL] [Abstract][Full Text] [Related]
10. Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer.
Yang X; Li J; Wang Y; Li P; Zhao Y; Duan W; Ariston Gabriel AN; Chen Y; Mao H; Wang Y; Du L; Wang C
Front Oncol; 2020; 10():515421. PubMed ID: 33194577
[TBL] [Abstract][Full Text] [Related]
11. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
Ping L; Zhang K; Ou X; Qiu X; Xiao X
Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
[No Abstract] [Full Text] [Related]
12. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer.
Zhang K; Ping L; Du T; Liang G; Huang Y; Li Z; Deng R; Tang J
Front Mol Biosci; 2021; 8():678877. PubMed ID: 34164433
[No Abstract] [Full Text] [Related]
13. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
14. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
15. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.
Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J
Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456
[TBL] [Abstract][Full Text] [Related]
16. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis of the Doxorubicin-Associated LncRNA-mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression.
Chen Q; Yang H; Zhu X; Xiong S; Chi H; Xu W
Front Genet; 2020; 11():566. PubMed ID: 32547604
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis.
Meng X; Li H; Fang E; Feng J; Zhao X
Front Oncol; 2020; 10():1411. PubMed ID: 32974147
[No Abstract] [Full Text] [Related]
19. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
20. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]